196 related articles for article (PubMed ID: 11562307)
1. Interest of acridine derivatives in the anticancer chemotherapy.
Demeunynck M; Charmantray F; Martelli A
Curr Pharm Des; 2001 Nov; 7(17):1703-24. PubMed ID: 11562307
[TBL] [Abstract][Full Text] [Related]
2. Acridine and its derivatives: a patent review (2009 - 2013).
Zhang B; Li X; Li B; Gao C; Jiang Y
Expert Opin Ther Pat; 2014 Jun; 24(6):647-64. PubMed ID: 24848259
[TBL] [Abstract][Full Text] [Related]
3. Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now?
Belmont P; Bosson J; Godet T; Tiano M
Anticancer Agents Med Chem; 2007 Mar; 7(2):139-69. PubMed ID: 17348825
[TBL] [Abstract][Full Text] [Related]
4. Niche for acridine derivatives in anticancer therapy.
Galdino-Pitta MR; Pitta MG; Lima MC; Galdino LS; Pitta RI
Mini Rev Med Chem; 2013 Jul; 13(9):1256-71. PubMed ID: 22697517
[TBL] [Abstract][Full Text] [Related]
5. [The structural and functional analysis of the biological activity of acridine derivatives].
Deeva EG; Pavlovskaia IaV; Kiselev OI; Kiselev VI; Piotrovskiĭ LB; Ershov FI
Vestn Ross Akad Med Nauk; 2004; (2):29-34. PubMed ID: 15101206
[TBL] [Abstract][Full Text] [Related]
6. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
7. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
Antonini I
Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
9. A Review on Acridines as Antiproliferative Agents.
Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
[TBL] [Abstract][Full Text] [Related]
10. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
11. Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.
Lang X; Li L; Chen Y; Sun Q; Wu Q; Liu F; Tan C; Liu H; Gao C; Jiang Y
Bioorg Med Chem; 2013 Jul; 21(14):4170-7. PubMed ID: 23735826
[TBL] [Abstract][Full Text] [Related]
12. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates.
Wang L; Price HL; Juusola J; Kline M; Phanstiel O
J Med Chem; 2001 Oct; 44(22):3682-91. PubMed ID: 11606133
[TBL] [Abstract][Full Text] [Related]
13. A new look at 9-substituted acridines with various biological activities.
Kozurkova M; Sabolova D; Kristian P
J Appl Toxicol; 2021 Jan; 41(1):175-189. PubMed ID: 32969520
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
15. Acridine derivatives as chemotherapeutic agents.
Denny WA
Curr Med Chem; 2002 Sep; 9(18):1655-65. PubMed ID: 12171548
[TBL] [Abstract][Full Text] [Related]
16. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
17. Current Scenario of Acridine Hybrids with Anticancer Potential.
Zhang Q; Yu X
Curr Top Med Chem; 2021; 21(19):1773-1786. PubMed ID: 34348622
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, DNA-binding and antiproliferative properties of acridine and 5-methylacridine derivatives.
Ferreira R; Aviñó A; Mazzini S; Eritja R
Molecules; 2012 Jun; 17(6):7067-82. PubMed ID: 22683895
[TBL] [Abstract][Full Text] [Related]
19. Acridine: a versatile heterocyclic nucleus.
Kumar R; Kaur M; Kumari M
Acta Pol Pharm; 2012; 69(1):3-9. PubMed ID: 22574501
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.
Chen J; Li D; Li W; Yin J; Zhang Y; Yuan Z; Gao C; Liu F; Jiang Y
Bioorg Med Chem; 2018 Aug; 26(14):3958-3966. PubMed ID: 29954683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
